AstraZeneca ADR earnings, Revenue beat in Q2

  • Investing.com
AstraZeneca ADR earnings, Revenue beat in Q2

Investing.com - AstraZeneca ADR reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

AstraZeneca ADR announced earnings per share of $1.72 on revenue of $10.77B. Analysts polled by Investing.com anticipated EPS of $0.7876 on revenue of $10.51B.

AstraZeneca ADR shares are up 14.54% from the beginning of the year and are trading at $66.72 , down-from-52-week-high.They are outperforming the Nasdaq which is down 22.26% year to date.

AstraZeneca ADR follows other major Healthcare sector earnings this month

AstraZeneca ADR's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.

J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles